{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007348","form_type":"8-K","ticker":"CDIX","cik":"0000811222","company_name":"Cardiff Lexington Corp","filed_at":"2026-09-24T11:59:53+00:00","discovered_at":"2026-09-24T13:00:03.502281+00:00","generated_at":"2026-09-24T13:00:13.103454+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cardiff Lexington signs LOI to acquire musculoskeletal platform for up to $104M","bullets":["LOI with owners of multi-location musculoskeletal platform; total purchase price up to $104 million.","Consideration: $30M cash at close, $10M notes due 2 years, preferred equity = 35% fully diluted, plus $12M stock earnout.","Earnout: $4M stock each if 2027 EBITDA >$15M, 2028 >$18M, 2029 >$22M.","Due diligence up to 45 days; target closing date November 16, 2026; financing not yet committed.","Proposed deal expands orthopedics, spine, pain management; sellers to retain leadership roles."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007348","json":"https://secwatch.observer/filing/0001683168-26-007348.json","markdown":"https://secwatch.observer/filing/0001683168-26-007348.md","text":"https://secwatch.observer/filing/0001683168-26-007348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/0001683168-26-007348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811222/000168316826007348/cardiff_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-24T13:00:13.103454+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}